Abstract
Summary Today, New Psychoactive Substances (NPS) are increasingly being related to post-mortem cases, and this problem drastically intensifies as a result of the New Synthetic Opioids (NSOs) surge. Among NSOs, fentanyl derivatives (FDs) consist in a myriad of drugs with a high turnover. FDs detection in human biological samples is complicated by low concentrations and usual extensive metabolism. In this challenging context, this manuscript aims to report analytical data about two poorly documented FDs: benzoylfentanyl (BZF) and parafluorobutyrfentanyl (pFBF). In 2018, these FDs were identified in three samples (powders and blotting papers) in France. Nuclear magnetic resonance and liquid chromatography with high-resolution mass spectrometry detection (LC-HRMS) data including observed mass spectrometric fragmentation patterns were obtained. In addition, metabolites were investigated using human liver microsomes incubations and LC-HRMS analysis: norBZF, despropionylfentanyl and a hydroxylated-BZF were identified (and observed in hair) as BZF metabolites; norpFBF, parafluorofentanyl and a hydroxylated-pFBF were identified as pFBF metabolites. In the worrisome context of NSOs detection, these preliminary data can be useful for toxicologists.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
